You are here

Article Text

Article menu
Download PDFPDF
Vulvar Cancer
The Use of Acellular Dermal Allograft for Vulvovaginal Reconstruction
  1. Michael P. Stany, MD*,
  2. Jan Sunde†,
  3. Michael A. Bidus, MD‡,
  4. G. Scott Rose, MD* and
  5. John C. Elkas, MD, JD§
  1. * Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Walter Reed Army Medical Center, Washington, DC;
  2. † Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Madigan Army Medical Center, Tacoma, WA;
  3. ‡ Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Portsmouth Naval Hospital, Portsmouth, VA; and
  4. § Northern Virginia Pelvic Surgery Associates, P.C., Fairfax, VA.
  1. Address correspondence and reprint requests to Michael P. Stany, MD, Walter Reed Army Medical Center, 6900 Georgia Ave, NW, Washington, DC 20307, USA. E-mail: michael.stany{at}amedd.army.mil.

Abstract

Background: Many different techniques that require the surgeon to harvest autologous tissue to create a neovagina have been described in the literature.

Technique: We describe a technique for creating a neovagina with the use of an acellular dermal allograft as a replacement for split-thickness skin graft. Three patients are presented who had a successful creation of a neovagina with this technique. The indications for vaginoplasty include vaginal agglutination from lichen planus, squamous cell carcinoma of the vagina, and vaginal agenesis.

Conclusion: The creation of a neovagina using an acellular dermal allograft can be successfully accomplished in patients undergoing constructive and exenterative procedures. The use of an acellular dermal allograft decreases operative time and decreases the incidence of postoperative morbidity because harvesting autologous tissue for the neovagina is not required.

  • Neovagina
  • Acellular dermal allograft
  • Exenteration

https://doi.org/10.1111/IGC.0b013e3181e2ed24

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • The authors of this article have received no financial support from LifeCell Corp and do not own stock in this company. None of the authors have acted as speaker or consultant for LifeCell Corp.